Table 4.

Per patient and per lesion sensitivity and specificity using generalized estimating equations (GEE) for target neurologic findings account for acute neurologic deficit.

Dose-Kernel Configuration	Per-patient Sensitivity for CT Findings Accounting for Acute Neurologic Deficit GEE % (95% C.I.) (range%)	Per-patient Specificity for CT Findings Accounting for Acute Neurologic Deficit GEE % (95% C.I.) (range%)	Target Lesion Sensitivity for CT Findings Accounting for Acute Neurologic Deficit GEE% (95% C.I.) (range%)
250 eff. mAs IR	81.7 (71.1 to 92.3) (78.6, 83.3)	93.5 (88.9 to 98.1) (85.4, 100.0)	71.0 (64.8 to 77.1) (65.7, 74.3)
200 eff. mAs FBP	79.4 (68.2 to 90.6) (76.2, 83.3)	91.9 (87.5 to 96.3) (80.5, 100.0)	68.6 (62.3 to 74.9) (61.4, 72.9)
100 eff. mAs IR	77.0 (65.5 to 88.5) (73.8, 81.0)	88.6 (82.8 to 94.4) (73.2, 95.1)	68.1 (61.8 to 74.4) (64.3, 71.4)
100 eff. mAs FBP	74.6 (62.4 to 86.8) (69.0, 78.6)	87.0 (81.1 to 92.9) (75.6, 95.1)	62.9 (56.3 to 69.4) (57.1, 65.7)
50 eff. mAs IR	73.8 (62.3 to 85.4) (66.7, 78.6)	88.6 (82.8 to 94.4) (75.6, 97.6)	60.5 (53.9 to 67.1) (52.9, 65.7)
50 eff. mAs FBP	72.2 (60.6 to 83.8) (71.4, 73.8)	83.7 (77.7 to 89.8) (69.8, 86.0)	61.0 (54.4 to 67.6) (60.0, 62.9)
25 eff. mAs IR	65.9 (53.3 to 78.4) (61.9, 71.4)	88.6 (82.4 to 94.8) (85.4, 92.7)	53.3 (46.6 to 60.1) (45.7, 62.9) [a]

^[a]95% confidence interval does not overlap with routine dose, so dose-reconstruction configuration is significantly worse.